Associate Principal Scientist
Merck & Co., Inc
Extensive pharmaceutical industry experiences in Analytical Chemistry. Worked on small molecule, oligonucleotide, antibody drug conjugate (ADC), and protein conjugate vaccine (PCV) therapeutics development and commercialization. Expertise areas include but not limited to ADC Payload linker control strategy planning, robust analytical method development for both small and large molecule, large molecule characterization using multi-detectors coupled with liquid chromatography. Her recent collaboration with Wyatt Technology enabled the simultaneous online RNA encapsulation determination of the lipid nanoparticle-based formulations. The publication was linked to the United Nations Sustainable Development Goals, helping to tackle some of the world’s greatest challenges.
Disclosure information not submitted.
Tuesday, April 25, 2023
2:30 PM – 3:30 PM ET
Tuesday, April 25, 2023
2:30 PM – 2:45 PM ET